mirvetuximab
immunogen
['mirasol', '$imgn']
canaccord raised pt $imgn $19 was $15/buy after full ph3 data at #asco23 showed what they call highly positive results in the phase 3 mirasol confirmatory study, demonstrating rapid &amp; consistent separation of the progression-free survival (pfs) &amp; overall survival (os) curves. 